Laura Kuensting
Pediatrics · Saint Louis, MONPI 1225247638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $49.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$840
- AbbVie$772
- GSK$738
- Supernus Pharmaceuticals, Inc.$492
- Tris Pharma Inc$424
- plus $5K from 33 others
What the payments were for
- Food & beverage$9,055100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $1,284 |
| Amgen | 8 | $840 |
| AbbVie | 9 | $772 |
| GSK | 19 | $738 |
| Supernus Pharmaceuticals, Inc. | 17 | $492 |
| Tris Pharma Inc | 15 | $424 |
| Pfizer | 11 | $360 |
| Ironshore Pharmaceuticals Inc. | 18 | $332 |
| Abbott | 3 | $297 |
| Kyowa Kirin, Inc. | 4 | $292 |
| Corium, LLC | 9 | $281 |
| Neurelis, Inc. | 7 | $254 |
| Edwards Lifesciences | 3 | $243 |
| Axsome Therapeutics, Inc. | 2 | $237 |
| Neurocrine Biosciences, Inc. | 2 | $208 |
| Novo Nordisk | 2 | $190 |
| Corcept Therapeutics | 2 | $190 |
| Teva Pharmaceuticals USA, Inc. | 2 | $180 |
| Sobi, Inc | 4 | $154 |
| Nestle Healthcare Nutrition Inc. | 3 | $145 |
| Sanofi Pasteur Inc. | 4 | $140 |
| Avanir Pharmaceuticals, Inc. | 1 | $120 |
| Sanofi | 1 | $119 |
| Bayer | 1 | $113 |
| Genentech USA, Inc. | 1 | $106 |
| Exeltis, USA Inc. | 1 | $102 |
| Gilead | 1 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| Adlon Therapeutics L.p. | 3 | $43 |
| Ironwood Pharmaceuticals, Inc | 2 | $41 |
| Alk-abello, Inc | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Sanofi-aventis U.S. LLC | 1 | $33 |
| Merck | 2 | $30 |
| Seqirus USA Inc | 1 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$444
- VRAYLAR$242
- Auvelity$237
- FREESTYLE LIBRE 3$162
- Repatha$132
- Creon$125
- INGREZZA$125
- Edwards SAPIEN 3 Transcatheter Heart Valve$123
- SHINGRIX$123
- VALTOCO$122
- QELBREE$122
- QULIPTA$122
- NOURIANZ$122
- BEXSERO$122
- Azstarys$122
- CRYSVITA$122
- NUEDEXTA$120
- DALVANCE$119
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$119
- DUPIXENT$119
How this compares
$9,056 in reported general payments places this provider in the 95th percentile of 1,306 pediatrics providers in Missouri.
Other pediatrics in Saint Louis
- Molly FiggemeierSaint Louis$74K
- Alexander FaySaint Louis$53K
- Natalie GoedekerSaint Louis$17K
- Gita MalurSaint Louis$12K
- Scott TrailSaint Louis$8K
- Donna ManleySaint Louis$6K
- Mark LevinSaint Louis$5K
- Ann HennesseySaint Louis$5K
- Prapti SinghSaint Louis$4K
- Jerome OneilSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.